Blowing The Whistle On Ranbaxy
Dinesh Thakur’s “whistleblower” complaint describes his 2004 investigation into the integrity of the data underlying Ranbaxy’s pending and approved drug applications and findings of systemic fraud.
Dinesh Thakur’s “whistleblower” complaint describes his 2004 investigation into the integrity of the data underlying Ranbaxy’s pending and approved drug applications and findings of systemic fraud.